MENU
DNLI
AS OF
Nov 13, 04:59 PM (EDT)
Price
$17.15
Change
-$0.37 (-2.11%)
Capitalization
2.57B
109 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
DNLI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Denali Therapeutics (DNLI) Earnings Date & Reports

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

DNLI is expected to report earnings to rise 1.88% to -75 cents per share on March 02

Denali Therapeutics DNLI Stock Earnings Reports
Q4'25
Est.
$-0.75
Q3'25
Beat
by $0.01
Q2'25
Missed
by $0.01
Q1'25
Missed
by $0.08
Q4'24
Beat
by $0.17
The last earnings report on November 06 showed earnings per share of -74 cents, beating the estimate of -75 cents. With 411.12K shares outstanding, the current market capitalization sits at 2.57B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
DNLI
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. DNLI showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for DNLI
A.I. Advisor
published General Information

General Information

a biotechnology company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
161 Oyster Point Boulevard
Phone
+1 650 866-8548
Employees
445
Web
https://www.denalitherapeutics.com